Please select the eligibility criteria that correspond to the clinical trial below.
Title: Online Treatments for Mood and Anxiety Disorders in Primary Care
Brief Summary: Depression and anxiety are common in primary care practice and are associated with substantial reductions in health-related quality of life. This Project will test the comparative effectiveness of two on-line treatments for these conditions provided through the context of a Collaborative Care program: (1) moderated access to a proven-effective computerized cognitive behavioral therapy (CCBT) program; versus (2) moderated access to CCBT plus an Internet support group (CCBT+ISG). The Project will also compare the effectiveness of these treatments to PCPs' "usual care" for these conditions, and evaluate the adoption and maintenance of CCBT+ISG by practices following the conclusion of the trial to provide a greater understanding of how to best scale the delivery of these interventions into a variety of primary care settings.


Options:
A: Inclusion Criteria:

* Diagnosis of mental illness or substance abuse
* Patient at Florida Hall (Grady Health Systems)

Exclusion Criteria:

* Current use of medical case management
B: Inclusion Criteria:

* 18-75 Years of age.
* Current major depression, panic, and/or generalized anxiety disorder on PRIME-MD.
* At least a moderate level of mood and/or anxiety symptoms (PHQ-9 ≥ 10 or a GAD-7 ≥ 10).
* Not receiving treatment for a mood or anxiety disorder from a mental health specialist.
* Has a telephone, e-mail address, and reliable access to the Internet.
* Stable medical condition and life expectancy greater than one year.

Exclusion Criteria:

* Active suicidal ideation or psychotic disorder.
* History of bipolar disorder.
* Alcohol dependence or other substance abuse disorder within the past three months.
* Plans to leave present source of care over the following year.
* Non-English speaking, illiterate, or having a visual or auditory barrier limiting ability to participate in telephone assessments, interventions, or provide signed, informed consent.
C: Inclusion Criteria:

* Diagnosis of bipolar disorder (I, II, not otherwise specified, or schizoaffective-bipolar subtype)
* Have a diagnosis or be at risk for arteriosclerotic cardiovascular disease (ASCVD).

We define this as a patient having a current diagnosis of or receiving treatment for at least one of the following medical conditions:

* hyperlipidemia or dyslipidemia (documented diagnosis or low-density lipoprotein \>=160, or receiving statin or other treatment)
* hypertension (documented diagnosis or blood pressure of \>=140/90 on 2 occasions)
* diabetes mellitus (documented diagnosis or HbA1C \>=7%, or receiving treatment)
* obesity (documented diagnosis or BMI \>30), based on medical record review of current problems
* current ASCVD diagnosis

Exclusion Criteria:

* Have unresolved substance intoxication or withdrawal, such as appearing to be intoxicated (e.g., incoherent, slurred speech), or experiencing withdrawal symptoms from substance abuse at the time of enrollment.
* Are already enrolled in a mental health program with a mobile outreach component in which clinical caregivers deliver services to the patient in the community (e.g., assertive community treatment or intensive case management). These patients may be receiving similar services to those offered in the intervention.
* Are unwilling or unable to provide informed consent or comply with study requirements at the time of enrollment (e.g., unable to complete forms or attend scheduled sessions due to serious illness or substantial functional limitations).
D: Inclusion Criteria:

* Persons with schizophrenia spectrum disorders

Exclusion Criteria:

* IQ \<70
* neurological disease diagnosis
* Active suicidality
* Severe drug abuse

Answer: B